RITROVA THERAPEUTICS INC. — Form D

RITROVA THERAPEUTICS INC. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-20. The offering totals $3.0M, of which $150K was reported sold. Industry: Other.

Offering

• Filed: 2021-01-20
• Form: D
• Accession: 0001841262-21-000001
• Industry: Other
• Exemptions: 06b
• Total offering: $3.0M
• Amount sold: $150K
• Remaining: $2.9M
• Investors: 2
• Date of first sale: 2021-01-11
• Revenue range: Decline to Disclose
• SEC file number: 021-386817

Issuer

• Name: RITROVA THERAPEUTICS INC.
• CIK: 0001841262
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 37 WASHINGTON SQUARE WEST, NEW YORK, NY, 10011
• Phone: 929-284-5678

Officers, directors & promoters (2)

More

• CIK 1841262 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search